Nirei, Kazushige <br/><br/>
Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients.  [electronic resource] 

 -  International journal of medical sciences  2017 
 - 45-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1449-1907 
<br/><br/><label>Standard No.: </label>10.7150/ijms.17202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Liver--drug effects<br/>Liver Cirrhosis--complications<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Non-alcoholic Fatty Liver Disease--etiology<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>Treatment Outcome